Log in

Relevant bibliographies by topics / Female Sexual Dysfunction (FSD) / Journal articles

To see the other types of publications on this topic, follow the link: Female Sexual Dysfunction (FSD).

Journal articles on the topic 'Female Sexual Dysfunction (FSD)'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Female Sexual Dysfunction (FSD).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Agarwal, Ritu. "Female Sexual Dysfunction among Indian Infertile Females." Journal of South Asian Federation of Obstetrics and Gynaecology 9, no. 2 (2017): 155–58. http://dx.doi.org/10.5005/jp-journals-10006-1482.

Full text

Abstract:

ABSTRACT Introduction Female sexual dysfunction (FSD) is very common among infertile patients. Whether FSD leads to infertility or infertility leads to FSD is still less understood. Objectives To study the prevalence of FSD and various factors that can lead to sexual dysfunction. Materials and methods This is a cross-sectional observational study conducted at a tertiary care center in Ahmedabad from June 2015 to March 2016. A total of 240 infertile patients in reproductive age group (20—47 years) were studied, for which informed consent was obtained. Female sexual dysfunction was assessed with

APA, Harvard, Vancouver, ISO, and other styles

2

Ragucci, Kelly R., and Nicole S. Culhane. "Treatment of Female Sexual Dysfunction." Annals of Pharmacotherapy 37, no. 4 (2003): 546–55. http://dx.doi.org/10.1345/aph.1c392.

Full text

Abstract:

OBJECTIVE: To review the pathophysiology and psychology of female sexual dysfunction (FSD) and describe potential prevention and treatment strategies for the disorder. DATA SOURCES: Articles identified from a MEDLINE search (1966–June 2002) using the term female sexual dysfunction. Additional references were obtained from cross referencing retrieved articles. STUDY SELECTION AND DATA EXTRACTION: After evaluating various review articles, clinical trials, and investigational studies, all information that was deemed relevant by the reviewers was included. DATA SYNTHESIS: FSD is a multicausal and

APA, Harvard, Vancouver, ISO, and other styles

3

Erdős, Csaba, Oguz Kelemen, Dávid Pócs, et al. "Female Sexual Dysfunction in Association with Sexual History, Sexual Abuse and Satisfaction: A Cross-Sectional Study in Hungary." Journal of Clinical Medicine 12, no. 3 (2023): 1112. http://dx.doi.org/10.3390/jcm12031112.

Full text

Abstract:

Female sexual dysfunction (FSD) has a negative impact on women’s quality of life, self-esteem, and physical health. The aim of the present study was to explore the prevalence and the factors associated with FSD using an online questionnaire. A cross-sectional survey was conducted among young adults (18−35 years old) in Hungary using the DSM-5 criteria. The participants (n = 5942) were divided into three major groups: FSD (20.3%), an intermediate group (43.9%), and a control group (35.6%). Most of the women showing FSD were affected with female orgasmic disorder (9.2%) and genito-pelvic pain/pe

APA, Harvard, Vancouver, ISO, and other styles

4

Gupta, Lovely, Swarnima Prakash, Deepak Khandelwal, Bharti Kalra, and Sanjay Kalra. "Diabetes and Female Sexual Dysfunction." US Endocrinology 14, no. 1 (2018): 35. http://dx.doi.org/10.17925/use.2018.14.1.35.

Full text

Abstract:

A normal sex life is an important part of life and relationships. Diabetes mellitus (DM) is an important cause of sexual dysfunction both in men and women. This problem is more difficult to diagnose and treat in women than in men because of the intricacy of the female sexual response. Also, the literature is limited addressing female sexual dysfunction (FSD) in DM, and this aspect of female health, is often ignored in clinical practice in women with DM. Early screening, diagnosis, and appropriate counseling are the cornerstone for managing FSD in women with DM. The current review aims to updat

APA, Harvard, Vancouver, ISO, and other styles

5

Lasheen, Yossra, Maged Elmohamady, Ahmed SA Ashour, Islam Abdelsatar Ibrahim Oweis, and Fatma Mohamed Magdyatta. "Prevelance and risk factors of female sexual dysfunction in females attending infertility clinic at Kasr Alainy hospital: a cross-sectional descriptive study." Obstetrics & Gynecology International Journal 15, no. 4 (2024): 159–67. http://dx.doi.org/10.15406/ogij.2024.15.00754.

Full text

Abstract:

Background: Female sexual dysfunction (FSD) is a common health problem that is inadequately investigated in Egypt. Sexual problems are reported by approximately 40 percent of females worldwide. There is a strong relationship between FSD, quality of life and infertility. Objective: The aim of this study is to assess the prevalence of female sexual dysfunction and also to investigate possible risk factors that may cause sexual dysfunction in the Egyptian infertile women seeking fertility Patients and Methods: This cross-sectional clinic-based survey was conducted at the infertility clinic, in Ka

APA, Harvard, Vancouver, ISO, and other styles

6

Zhong, Qing, and Yuri Anderson. "Management of Hypertension with Female Sexual Dysfunction." Medicina 58, no. 5 (2022): 637. http://dx.doi.org/10.3390/medicina58050637.

Full text

Abstract:

Female sexual dysfunction (FSD) in hypertension has been less studied than male sexual dysfunction, and antihypertensive agents’ impact on female sexual function is not defined. In this review, randomized double-blind clinical trials and cross-sectional studies related to female sexual function in hypertension were analyzed from 1991 to 2021. FSD appeared to be higher in hypertensive women than in normotensive women. Beta-blockers are the only antihypertensive agents with relatively strong evidence of damaging the female sexual function. Angiotensin receptor blockers (ARB) are relatively benef

APA, Harvard, Vancouver, ISO, and other styles

7

Lodha, Pragya, and Avinash De Sousa1,. "Female Sexual Dysfunction and Schizophrenia: A Clinical Review." Journal of Psychosexual Health 2, no. 1 (2020): 44–55. http://dx.doi.org/10.1177/2631831820916096.

Full text

Abstract:

Female sexual dysfunction (FSD) is understudied and unexplored in clinical practice. There is a need for psychiatrists to acknowledge the same and explore this symptom in patients with schizophrenia. The following article is a clinical review that looks at various facets of FSD in relation to schizophrenia. The various types of FSD seen in schizophrenia are elaborated and factors that affect the same are discussed. The role of various factors and antipsychotic-induced FSD is also discussed. The role of estrogens in women with schizophrenia from a clinical and sexual perspective, the role of or

APA, Harvard, Vancouver, ISO, and other styles

8

Zamponi, Virginia, Pina Lardo, Roberta Maggio, et al. "Female Sexual Dysfunction in Primary Adrenal Insufficiency." Journal of Clinical Medicine 10, no. 13 (2021): 2767. http://dx.doi.org/10.3390/jcm10132767.

Full text

Abstract:

Purpose. No data are currently available on female sexual dysfunction (FSD) in primary adrenal insufficiency (PAI) and the possible impact of replacement therapy. The aim of this study was to evaluate the prevalence of FSD and sexual distress (SD), and to evaluate the possible impact of replacement therapy on sexuality in women with PAI. Methods. Female Sexual Function Index-6 (FSFI-6) and Sexual Distress Scale (SDS) questionnaires were administered to 22 women with PAI and 23 healthy women matched for age as controls. Results. The prevalence of sexual symptoms measured by FSFI-6 (total score

APA, Harvard, Vancouver, ISO, and other styles

9

Guay, André T. "Female Sexual Dysfunction: Hormonal Treatment of FSD." Journal of Sexual Medicine 4 (January 2007): 49. http://dx.doi.org/10.1111/j.1743-6109.2007.00371.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tamisa Leonel, Alana. "Prevalência de disfuncao sexual feminina em Guarapuava PR." Revista Brasileira de Fisioterapia Pelvica 3, no. 1 (2023): 15–25. http://dx.doi.org/10.62115/rbfp.2023.3(1)15-25.

Full text

Abstract:

Background: Sexuality is part of human health, reflecting on people's well-being and quality of life. Female Sexual Dysfunction (FSD) is associated with difficulty in maintaining sexual responses, altering painful, sexual, substitutive perceptions and orgasm. Due to its subjectivity, it needs evaluative instruments that address multiple issues. This is possible through self-assessment tests and can be done online, promoting the guarantee of a reliable, valid and wide collection. Aims: To describe the prevalence of female sexual dysfunction in sexually active women in the city of Guarapuava/PR

APA, Harvard, Vancouver, ISO, and other styles

11

Rohina, S. Aggarwal, V. Mishra Vineet, A. Panchal Navin, H. Patel Nital, V. Deshchougule Vrushali, and F. Jasani Anil. "Incidence and Prevalence of Sexual Dysfunction in Infertile Females." Bangladesh Journal of Obstetrics & Gynaecology 28, no. 1 (2016): 26–30. http://dx.doi.org/10.3329/bjog.v28i1.29936.

Full text

Abstract:

Introduction: The sexual response in women is complex. The association of infertility and sexual dysfunction is overlapping.Objective: To find the incidence and prevalence of female sexual dysfunction in infertile females and its correlation with infertility.Material and Methods:Total of 500 patients in the age group of 24-42 years participated in the prospective study. They were assigned fertile and infertile group. Female sexual dysfunction was assessed according to FSFI questionnaire. Patients with past history of any psychiatric illness, endocrinological disorder e.g. diabetes mellitus or

APA, Harvard, Vancouver, ISO, and other styles

12

Bae, Jeong-Yee. "A Study on Female Sexual Dysfunction, Marital Accommodation, Depression and Crisis in Korean Women." Journal of Korean Academy of psychiatric and Mental Health Nursing 13, no. 4 (2004): 467–75. http://dx.doi.org/10.12934/jkpmhn.2004.13.4.467.

Full text

Abstract:

Purpose: Although concerns for female sexual dysfunction (FSD) are increasing in Korea, it is very limited in basic study for prevalence of FSD or sexual dysfunction-related factors. The aim of this study was to establish the basic data for FSD and FSD-related factors in regional urban and rural area of Korea. Methods: Three hundred twenty five women aged over 20 year-old and resident in regional urban and rural area were analyzed by visit-survey with an organized questionnaire. Female sexual function index (FSFI) for measurement of sexual dysfunction and depression scale, marital accommodatio

APA, Harvard, Vancouver, ISO, and other styles

13

Liu, Jing, Yina Zhang, and Xu Mao. "Factors Contributing to Sexual Dysfunction in Female Schizophrenia Patients During Recovery: A Multifactorial Analysis." Actas Españolas de Psiquiatría 53, no. 2 (2025): 237–44. https://doi.org/10.62641/aep.v53i2.1867.

Full text

Abstract:

Background: Female patients with schizophrenia may experience sexual dysfunction during the recovery period. Therefore, this study conducted a multifactorial analysis to identify factors impacting sexual dysfunction, aiming to aid in developing effective personalized intervention strategies and improving sexual function recovery in these patients. Methods: This retrospective study included the clinical data from 261 female schizophrenia patients treated at the First Affiliated Hospital of Jinzhou Medical University, diagnosed between February 2022 and March 2024. Based on the total Female Sexu

APA, Harvard, Vancouver, ISO, and other styles

14

A Ismail, Sahar, Nagwa E Abdel-Azim, Medhat A Saleh, Ahmed A Mohamed, Ali H Yosef, and Ahmad M Abbas. "A new grading system for female sexual dysfunction based on the female sexual function index in Egyptian women: a cross-sectional study." African Health Sciences 21, no. 2 (2021): 835–41. http://dx.doi.org/10.4314/ahs.v21i2.44.

Full text

Abstract:

Objective: To provide a grading system that accurately reflects the grades of female sexual dysfunction (FSD) severity. Patients and methods: A cross-sectional study was conducted in Assiut University Hospital. It included 500 women who answered the Arabic version of the Female Sexual Function Index (FSFI) after getting their consent. A gradient of FSD severity was created, classifying FSD into five grades: severe, moderate, mild to moderate, mild, and no FSD. Results: According to our grading system, FSD was detected in 339 women (67.8 %); Mild FSD in 20.4%, mild to moderate in 41

APA, Harvard, Vancouver, ISO, and other styles

15

Mereu, A. "Female sexual dysfunction after breast cancer surgery prediction with AI." European Psychiatry 64, S1 (2021): S604. http://dx.doi.org/10.1192/j.eurpsy.2021.1612.

Full text

Abstract:

IntroductionFemale sexual dysfunction (FSD) can be overlooked. Different types of breast cancer surgery could have a different impact on the sexuality of women. Artificial intelligence (AI) could help to determine the relation between those conditions.ObjectivesTo investigate whether AI could predict FSD relying primarily on the time elapsed after treatment and the type of breast cancer surgery.MethodsData of age, time elapsed after treatment and type of surgery (breast-conserving therapy and mastectomy) were employed to predict FSD status in 128 subjects using an AI. Women with and without st

APA, Harvard, Vancouver, ISO, and other styles

16

Reda, Mona, and Dina Ruby. "Female Sexual Dysfunction Among a Sample of Egyptian Patients with Asthma." Open Respiratory Medicine Journal 14, no. 1 (2020): 38–44. http://dx.doi.org/10.2174/1874306402014010038.

Full text

Abstract:

Background: Despite asthma being a worldwide disease, still little awareness regarding the sexual function of asthmatic patients exists. So this study attempts to assess the Female Sexual Dysfunction (FSD) amongst Egyptian females with asthma and its burden on their quality of life. Materials & Methods: The sample consisted of 180 subjects, comprising 90 asthma patients and 90 healthy controls aged between 20 - 45 years old, who visited the Chest Department Outpatient Clinic of Ain Shams University Hospital between January and December 2018. We reported all the subjects' demographic and cl

APA, Harvard, Vancouver, ISO, and other styles

17

Hirsch, Irvin H., Steven Mandel, and Christopher R. Brigham. "Sexual Dysfunction Impairment." Guides Newsletter 6, no. 5 (2001): 1–4. http://dx.doi.org/10.1001/amaguidesnewsletters.2001.sepoct01.

Full text

Abstract:

Abstract Male sexual dysfunction (MSD) and female sexual dysfunction (FSD) may be of multifactorial etiology; rating these disorders heretofore has been based on subjective, patient-reported criteria. This article discusses the process of determining sexual disability by incorporating objective, laboratory-based data in order to render more reliable and valid determinations, including whether the patient has received appropriate treatment and is at maximum medical improvement. MSD is of organic, psychogenic, mixed, or indeterminate cause, and identification of specific MSD etiology can be made

APA, Harvard, Vancouver, ISO, and other styles

18

Burri, A., Q. Rahman, and T. Spector. "Genetic and environmental risk factors for sexual distress and its association with female sexual dysfunction." Psychological Medicine 41, no. 11 (2011): 2435–45. http://dx.doi.org/10.1017/s0033291711000493.

Full text

Abstract:

BackgroundThe DSM-V Working Group is currently re-evaluating distress as a primary diagnostic criterion for female sexual dysfunction (FSD). Here, for the first time, we explored the epidemiology of sexual distress and its putative aetiological relationship to FSD by estimating the influence of genetic and environmental risk factors.MethodQuestionnaire data on a representative sample of 930 British female twins using validated scales of FSD and sexual distress were subject to variance components analyses to quantify latent genetic and environmental factors influencing phenotypic variation and

APA, Harvard, Vancouver, ISO, and other styles

19

El-Ammawi, Tarek S., Rasha T. A. Abdel-Aziz, Doaa S. Taha, and Sahar S. Mohammed. "Effect of chronic skin disease on female sexual function (FSF) among married Egyptian women." Egyptian Journal of Dermatology and Venereology 43, no. 3 (2023): 178–85. http://dx.doi.org/10.4103/ejdv.ejdv_48_22.

Full text

Abstract:

Background Female sexual dysfunction (FSD) is a term used to describe various sexual problems, such as low desire or interest, diminished arousal, orgasmic difficulties, and dyspareunia. Objectives The aim of the present study was to determine the effect of chronic skin disease on female sexual function among married Egyptian females as well as the prevalence of FSD among them and its effect on their husbands. Patients and methods The study was conducted on 300 sexually active married Egyptian women attending the Dermatology Outpatient Clinic of Minia University Hospital and Kom Elshokafa Clin

APA, Harvard, Vancouver, ISO, and other styles

20

Elanjian, Alissa I., Sesilia Kammo, Lyndsey Braman, and Aron Liaw. "Advancing Women’s Health: A Scoping Review of Pharmaceutical Therapies for Female Sexual Dysfunction." Sexes 6, no. 3 (2025): 38. https://doi.org/10.3390/sexes6030038.

Full text

Abstract:

Background: Female Sexual Dysfunction (FSD) encompasses a range of conditions that can profoundly impact quality of life and intimate relationships. The primary classifications of FSD include female sexual interest and arousal disorder (FSIAD), genitopelvic pain and penetration disorder (GPPPD), female orgasmic disorder (FOD), and substance or medication-induced sexual dysfunction (SM-ISD). Despite its prevalence, FSD is often underdiagnosed and undertreated. Objectives: This scoping review follows Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to evalua

APA, Harvard, Vancouver, ISO, and other styles

21

Kryzhanovska, O. I. "Clinical characteristics of women with female sexual dysfunction and endometriosis." UKRAINIAN JOURNAL HEALTH OF WOMAN, no. 1(170) (February 28, 2024): 32–37. http://dx.doi.org/10.15574/hw.2024.170.32.

Full text

Abstract:

Endometriosis is a disease characterized by the presence of endometrial tissue outside the uterine cavity. Endometriosis refers to estrogen-dependent diseases, clinically manifested by dysmenorrhea, dyspareunia, dyschezia. Decreased fertility in women with endometriosis is associated with the presence of chronic inflammation that leads to pelvic pain and infertility. It is believed that endometriosis is associated with mood disorders such as anxiety or depression, which can create a pathological background for sexual dysfunction. Purpose - to establish the relationship between female sexual dy

APA, Harvard, Vancouver, ISO, and other styles

22

Alselaiti, Mariam, Maha A. Saleh, Hana Muhammed, Elham Attallah, and Nawal Dayoub. "Prevalence of Female Sexual Dysfunction and Barriers to Seeking Primary Health Care Treatment in an Arab Male-Centered Regime." Open Access Macedonian Journal of Medical Sciences 10, E (2022): 493–97. http://dx.doi.org/10.3889/oamjms.2022.8771.

Full text

Abstract:

BACKGROUND: The prevalence of female sexual dysfunction (FSD) is a common health issue and women living in male-centered regimes are more vulnerable to have FSD. AIM: This study was conducted to estimate the prevalence of FSD in Bahrain, which is male-centered and impacted with cultural and Islamic religious standards, and the associated variables with FSD, including the barriers to seeking medical help from health-care professionals. METHODS: This study was a cross-sectional design based on interview questions of 360 married women between 18 and 60 years of age who randomly visited one of thr

APA, Harvard, Vancouver, ISO, and other styles

23

Miller, Heather B., and Jacquelyn S. Hunt. "Female Sexual Dysfunction: Review of the Disorder and Evidence for Available Treatment Alternatives." Journal of Pharmacy Practice 16, no. 3 (2003): 200–208. http://dx.doi.org/10.1177/0897190003016003008.

Full text

Abstract:

With the introduction and marketing of sildenafil, national attention has focused on sexual dysfunction in men. However, strides are being made to focus more effort on evaluation and treatment of female sexual disorder (FSD) since a 1999 national survey reported prevalence rates as high as 43% in women. Evaluation and assessment of FSD requires a comprehensive history and physical examination. Understanding of FSD requires knowledge and understanding of sexual anatomy, physiology, and pathophysiology. Nonpharmacologic treatment may include sex therapy or relationship counseling. Pharmacologic

APA, Harvard, Vancouver, ISO, and other styles

24

Aggarwal, Rohina S., Vineet V. Mishra, Navin A. Panchal, Nital H. Patel, Vrushali V. Deshchougule, and Anil F. Jasani. "Sexual Dysfunction in Women: An Overview of Risk Factors and Prevalence in Indian Women." Journal of South Asian Federation of Obstetrics and Gynaecology 4, no. 3 (2012): 134–36. http://dx.doi.org/10.5005/jp-journals-10006-1195.

Full text

Abstract:

ABSTRACT Objective To detect the prevalence of sexual dysfunction and also to investigate possible risk factors that may cause sexual dysfunction in the Indian women. Materials and methods The prospective study consisted of 500 women between ages 18 and 66 years from different sociocultural areas. The women were divided into five groups according to their ages <24 years (n = 129), 24 to 30 years (n = 182), 31 to 37 years (n = 125), 38 to 42 years (n = 22), >42 years (n = 42). Female sexual function was assessed with a detailed 19-item FSFI questionnaire to evaluate five domains of sexual

APA, Harvard, Vancouver, ISO, and other styles

25

How, Andrew, Christopher Jowdy, Elli Novatcheva, and Anita H. Clayton. "Novel Pharmacologic Treatments of Female Sexual Dysfunction." Clinical Obstetrics & Gynecology 68, no. 1 (2025): 10–14. https://doi.org/10.1097/grf.0000000000000922.

Full text

Abstract:

This review evaluates pharmacologic treatments for female sexual dysfunction (FSD), focusing on hypoactive sexual desire disorder (HSDD). We provide clinically relevant applications for Food and Drug Administration (FDA)-approved medications (flibanserin and bremelanotide) and investigational therapies (Lorexys and testosterone combinations). Detailed study outcomes, safety profiles, and clinical strategies guide clinicians in appropriate diagnosis, patient selection, expectation setting, side effect management, and patient education, improving treatment outcomes and patient satisfaction.

APA, Harvard, Vancouver, ISO, and other styles

26

Ng, Ying Ying, Rosediani Muhamad, and Imran Ahmad. "Sexual dysfunction among six months postpartum women in north-eastern Malaysia." PLOS ONE 18, no. 4 (2023): e0284014. http://dx.doi.org/10.1371/journal.pone.0284014.

Full text

Abstract:

Female sexual dysfunction (FSD) is a common problem among postpartum women. However, little is known about this topic in Malaysia. This study aimed to determine the prevalence of sexual dysfunction and its associated factors in postpartum women in Kelantan, Malaysia. In this cross-sectional study, we recruited 452 sexually active women at six months postpartum from four primary care clinics in Kota Bharu, Kelantan, Malaysia. The participants were asked to fill in questionnaires consisting of sociodemographic information and the Malay Version of the Female Sexual Function Index-6. The data were

APA, Harvard, Vancouver, ISO, and other styles

27

Qing, Guangwei, Hao He, Minghao Lai, Xue Li, Yan Chen, and Bo Wei. "Systemic immune-inflammatory index and its association with female sexual dysfunction, specifically low sexual frequency, in depressive patients: Results from NHANES 2005 to 2016." Medicine 103, no. 22 (2024): e38151. http://dx.doi.org/10.1097/md.0000000000038151.

Full text

Abstract:

Sexual dysfunction, particularly in females, is a complex issue influenced by various factors, including depression and inflammation. The Systemic immune-inflammation index (SII), an inflammatory biomarker, has shown associations with different health conditions, but its relationship with female sexual dysfunction (FSD) remains unclear. This study aimed to investigate the association between SII and FSD in the context of depression, utilizing low sexual frequency as an assessment indicator. Data from the National Health and Nutrition Examination Survey (NHANES) 2005 to 2016, involving 1042 dep

APA, Harvard, Vancouver, ISO, and other styles

28

Callens, Nina, Guy Bronselaer, Petra De Sutter, et al. "Costs of pleasure and the benefits of pain: self-perceived genital sensation, anatomy and sexual dysfunction." Sexual Health 13, no. 1 (2016): 63. http://dx.doi.org/10.1071/sh15160.

Full text

Abstract:

Background Research has highlighted the complex association between female sexual dysfunction (FSD) and distress regarding sexual activity, with decreased physical pleasure being an important mediator. The current study aims to elucidate the association between pleasurable and painful genital sensitivity and FSD, and to further investigate whether FSD may be distressing because it prevents the experience of sexual pleasure, induces pain or both. Methods: Sexually active women (n = 256; median, 22 years; range, 18–49 years) completed web-based questionnaires, including the Self-Assessment of Ge

APA, Harvard, Vancouver, ISO, and other styles

29

Tzortzis, Vassilios, Konstantinos Skriapas, George Hadjigeorgiou, et al. "Sexual dysfunction in newly diagnosed multiple sclerosis women." Multiple Sclerosis Journal 14, no. 4 (2008): 561–63. http://dx.doi.org/10.1177/13524585080140040901.

Full text

Abstract:

Objectives The aim of the study was to evaluate female sexuality in a selective population of newly diagnosed multiple sclerosis (MS) women. Materials and methods In this clinic-based study, 63 newly diagnosed consecutive women affected by definite MS were admitted. Disability and depression were evaluated with the expanded disability status scale (EDSS) and Beck depression inventory, respectively. Sexual function was evaluated with the female sexual function index (FSFI). A group of 61 healthy female volunteers with the same baseline characteristics were used as controls. Postmenopausal women

APA, Harvard, Vancouver, ISO, and other styles

30

Hanafy, Samy, Neveen E. Srour, and Taymour Mostafa. "Female sexual dysfunction across the three pregnancy trimesters: an Egyptian study." Sexual Health 11, no. 3 (2014): 240. http://dx.doi.org/10.1071/sh13153.

Full text

Abstract:

Background Pregnancy is a special period in the life of women characterised by physical, hormonal and psychological changes that, in conjugation with social and cultural influences, could affect women’s sexuality as well as couples’ sexual relationships. This cross-sectional study aimed to evaluate female sexual dysfunction (FSD) among the three pregnancy trimesters. Methods: A total of 300 healthy heterosexual pregnant Egyptian women with stable marital relationships were included. The Female Sexual Function Index (FSFI) questionnaire was used as a standard method for measuring female sexual

APA, Harvard, Vancouver, ISO, and other styles

31

Stamatiou, Konstantinos, Maria Margariti, Eftichia Nousi, Dimitra Mistrioti, Richard Lacroix, and and Saridi. "Female Sexual Dysfunction (FSD) in Women Health Care Workers." Materia Socio Medica 28, no. 3 (2016): 178. http://dx.doi.org/10.5455/msm.2016.28.178-182.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Lynn, Becky K., Julia D. López, Morgan E. Link, and E. Cristian Campian. "Cannabis Use in Women and Sexual Dysfunction." Sexes 6, no. 3 (2025): 31. https://doi.org/10.3390/sexes6030031.

Full text

Abstract:

The purpose of this study is to evaluate the differences in sexual functioning in women who used cannabis before sex and those who used cannabis but not before sex, among those with sexual dysfunction. The cross-sectional study, conducted from August 2019 to January 2020 at an academic sexual dysfunction clinic in the Midwest region of the United States, included 187 participants. Patients completed an anonymous questionnaire during their visit, which included the Female Sexual Function Index (FSFI), cannabis use, and sociodemographic factors. The primary objective of this study was to assess

APA, Harvard, Vancouver, ISO, and other styles

33

Daescu, Ana-Maria Cristina, Dan-Bogdan Navolan, Liana Dehelean, et al. "The Paradox of Sexual Dysfunction Observed during Pregnancy." Healthcare 11, no. 13 (2023): 1914. http://dx.doi.org/10.3390/healthcare11131914.

Full text

Abstract:

The aim of this study is to analyze the evolution of sexual function throughout pregnancy and highlight the predicting factors of sexual dysfunction in pregnant women. Our study included 144 participants, aged 16 to 45. Patients were evaluated three times during pregnancy by filling out the Female Sexual Function Index (FSFI) and the Body Exposure in Sexual Activities Questionnaire (BESAQ). At the time of the last evaluation, we asked patients to also fill out Beck’s Depression Inventory (BDI-II) and a questionnaire regarding their psychological status and relationship satisfaction. We observe

APA, Harvard, Vancouver, ISO, and other styles

34

Sreelakshmy, Krishnankutty, Rajmohan Velayudhan, Deepak Kuriakose, and Rema Nair. "Sexual dysfunction in females with depression: a cross-sectional study." Trends in Psychiatry and Psychotherapy 39, no. 2 (2017): 106–9. http://dx.doi.org/10.1590/2237-6089-2016-0072.

Full text

Abstract:

Abstract Introduction Female sexual dysfunction (FSD) in depression albeit common is strikingly understudied. The condition, if addressed properly, can be readily cured, improving the quality of life of the patient. Methods A consecutive sample of drug-naïve married female patients with depression was assessed. Depression was diagnosed using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Depression severity was assessed using the Hamilton Depression Rating Scale (HAM-D), and sexual dysfunction, the Female Sexual Function Index (FSFI). Results Sexual dysfunction was fou

APA, Harvard, Vancouver, ISO, and other styles

35

Bostani Khalesi, Zahra, Fatemeh Jafarzadeh-Kenarsari, Yalda Donyaei Mobarrez, and Mahmood Abedinzade. "The impact of menopause on sexual function in women and their spouses." African Health Sciences 20, no. 4 (2020): 1979–84. http://dx.doi.org/10.4314/ahs.v20i4.56.

Full text

Abstract:

Background: The purpose of this study is to evaluate the impact of menopause on sexual function in women and their spouses. Methods: This is a cross-sectional study that was conducted from January 2018 to May 2019 in Rasht (North of Iran). The participants included 215 menopausal women and their spouses. Data were collected using the demographic questionnaire, the Female Sexual Function Index (FSFI) questionnaire, and the International Index of Erectile Function (IIEF) question- naire. Results: On the basis of the FSFI and IIEF scores, 36.28% (78/215) women reported female sexual d

APA, Harvard, Vancouver, ISO, and other styles

36

Zachariou, Athanasios, Ioannis Giannakis, Aris Kaltsas, et al. "Percutaneous Tibial Nerve Stimulation’s Impact on Sexual Function in Female Patients with Neurogenic Detrusor Overactivity, Sexual Dysfunction, and Multiple Sclerosis." Journal of Clinical Medicine 13, no. 20 (2024): 6042. http://dx.doi.org/10.3390/jcm13206042.

Full text

Abstract:

Background/Objectives: Multiple sclerosis (MS) frequently results in both urinary and sexual dysfunction, which significantly impairs quality of life. Conventional treatments for bladder dysfunction often prove insufficient, leading to the exploration of alternative therapies such as percutaneous tibial nerve stimulation (PTNS). This study aimed to assess the impact of PTNS on sexual function and bladder symptoms in female MS patients with neurogenic detrusor overactivity (NDO) and female sexual dysfunction (FSD). Methods: A total of 65 female MS patients with NDO were evaluated and underwent

APA, Harvard, Vancouver, ISO, and other styles

37

Bortun, Ana-Maria Cristina, Viviana Ivan, Dan-Bogdan Navolan, Liana Dehelean, Andreea Borlea, and Dana Stoian. "Thyroid Autoimmune Disease—Impact on Sexual Function in Young Women." Journal of Clinical Medicine 10, no. 2 (2021): 369. http://dx.doi.org/10.3390/jcm10020369.

Full text

Abstract:

The important prevalence of autoimmune thyroid disease (AITD) in the general population was the main motivation for conducting the present study. The present paper aims to estimate the possible comorbidities related to female sexual dysfunction (FSD) and depression related to AITD. The study group consisted of 320 patients: 250 cases known with untreated AITD, divided into subgroups (euthyroid subgroup, subclinical hypothyroidism subgroup and clinical hypothyroidism subgroup); respectively 70 healthy females in the control group. Patients underwent thyroid evaluation, ovarian evaluation and la

APA, Harvard, Vancouver, ISO, and other styles

38

Gruenwald, Ilan, Yoram Vardi, Irena Gartman, et al. "Sexual dysfunction in females with multiple sclerosis: quantitative sensory testing." Multiple Sclerosis Journal 13, no. 1 (2007): 95–105. http://dx.doi.org/10.1177/1352458506071134.

Full text

Abstract:

Introduction and objectives Female sexual dysfunction (FSD) is highly prevalent (45–74%) in multiple sclerosis (MS) patients. Quantitative sensory testing (QST) has recently been used to assess normal neural function of the female genitalia. In this study we used QST for assessment of the genital neural function of female MS patients. Materials and methods We examined 41 female MS patients aged 21–56, with 10 years median disease duration. Each patient had a neurological examination, and evaluation of sexual function (SF) by both questionnaire and a focused interview. QST wasperformed at the c

APA, Harvard, Vancouver, ISO, and other styles

39

Sancak, Eyup Burak, Sevilay Oguz, Tugba Akbulut, et al. "Female sexual dysfunction in androgenetic alopecia: Case-control study." Canadian Urological Association Journal 10, no. 7-8 (2016): 251. http://dx.doi.org/10.5489/cuaj.3582.

Full text

Abstract:

<p><strong>Introduction:</strong> We sought to evaluate the association of female sexual dysfunction (FSD) with adrogenetic alopecia (AGA) and metabolic syndrome (MetS) in premenopausal women.</p><p><strong>Methods:</strong> From December 2013 to June 2015, we performed a case-control, prospective study of 115 patients with AGA and 97 age-matched control patients without AGA from among premenopausal<br />women who visited dermatology clinics of the two reference hospitals. Comprehensive history, anthropometric measurements, and questionnaire admi

APA, Harvard, Vancouver, ISO, and other styles

40

Loh, Huai H., Mohammad A. Shahar, Huai S. Loh, and Anne Yee. "Female sexual dysfunction after bariatric surgery in women with obesity: A systematic review and meta-analysis." Scandinavian Journal of Surgery 111, no. 1 (2022): 145749692110723. http://dx.doi.org/10.1177/14574969211072395.

Full text

Abstract:

Background and objective: Obesity is prevalent and has a negative impact on women’s health, including sexual dysfunction. Recent review articles suggest improvement in Female Sexual Function Index (FSFI) and proportion of female sexual dysfunction (FSD) among women with obesity after bariatric surgery. Methods: We pooled data from 16 observational studies involving 953 women. The study outcomes were mean FSFI scores and proportion of FSD before and after bariatric surgery. We also sub-analyzed whether age and duration of follow-up affected these outcomes. Results: The mean age of the subjects

APA, Harvard, Vancouver, ISO, and other styles

41

Katsimardou, Alexandra, Dimitrios Patoulias, Ioanna Zografou, et al. "The Associations between Kidney Function and Sexual Dysfunction among Males and Females with Type 2 Diabetes Mellitus." Medicina 59, no. 5 (2023): 969. http://dx.doi.org/10.3390/medicina59050969.

Full text

Abstract:

Background and Objectives: Diabetic kidney disease (DKD), expressed either as albuminuria, low estimated glomerular filtration rate (eGFR) or both, and sexual dysfunction (SD), are common complications among type 2 diabetes mellitus (T2DM) patients. This study aims to assess whether an association exists between DKD and SD, erectile dysfunction (ED) or female sexual dysfunction (FSD) in a T2DM population. Materials and Methods: A cross-sectional study was designed and conducted among T2DM patients. The presence of SD was assessed using the International Index of Erectile Function and the Femal

APA, Harvard, Vancouver, ISO, and other styles

42

Hidalgo-Lopezosa, Pedro, Sandra Pérez-Marín, Andrea Jiménez-Ruz, et al. "Factors Associated with Postpartum Sexual Dysfunction in Spanish Women: A Cross-Sectional Study." Journal of Personalized Medicine 12, no. 6 (2022): 926. http://dx.doi.org/10.3390/jpm12060926.

Full text

Abstract:

(1) Background: Female sexual dysfunction (FSD) has a high prevalence globally, and perinatal factors favor FSD, especially in the postpartum period. The aim was to determine the prevalence and factors influencing FSD in the postpartum period; (2) Methods: An observational study carried out in three primary care centers in southern Spain, with women in the postpartum period who had a single low-risk birth. One hundred and seventeen women answered the Female Sexual Function questionnaire during the 4th month postpartum, between January 2020 and December 2021. Sociodemographic, obstetric, neonat

APA, Harvard, Vancouver, ISO, and other styles

43

Avcı, Corc, Olgu Aygün, and Dilek Güldal. "Association between sexual dysfunction, self-esteem and sexual satisfaction in women." Aegean Journal of Obstetrics and Gynecology 5, no. 1 (2023): 5–10. http://dx.doi.org/10.46328/aejog.v5i1.134.

Full text

Abstract:

ABSTRACT Backround: The main purpose of this study is to investigate the relationships among female sexual dysfunction, self-esteem and sexual satisfaction. Method: The participants of the study were 321 women who applied for any sexual disorders to the Polyclinics of Gynecology of y Education and Research Hospital, x, Turkey. Their age ranged from 18 to 56. The participants completed a personal information form prepared by researcher, the Coopersmith Self-esteem Inventory developed by Stanley Coopersmith (1986) and the Golombok-Rust Inventory of Sexual Satisfaction validated by Tu

APA, Harvard, Vancouver, ISO, and other styles

44

Tiefer, Leonore. "Female sexual dysfunction (FSD): witnessing social construction in action 1." Sexualities, Evolution & Gender 5, no. 1 (2003): 33–36. http://dx.doi.org/10.1080/14616660310001594962.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Daescu, Ana-Maria Cristina, Liana Dehelean, Dan-Bogdan Navolan, Alexandru-Ioan Gaitoane, Andrei Daescu, and Dana Stoian. "Effects of Hormonal Profile, Weight, and Body Image on Sexual Function in Women with Polycystic Ovary Syndrome." Healthcare 11, no. 10 (2023): 1488. http://dx.doi.org/10.3390/healthcare11101488.

Full text

Abstract:

Polycystic ovary syndrome (PCOS) is a hyperandrogenic endocrinological disorder associated with chronic oligo-anovulation and polycystic ovarian morphology. Compared to women without PCOS, women with PCOS have a risk of sexual dysfunction that is more than 30% higher. Although alterations in sex hormones and psychosocial wellbeing have been proposed, the precise mechanisms of FSD in PCOS remain unclear. The aim of our study was to analyze how the hormonal, clinical and psychometric parameters of PCOS patients are involved in the development of sexual dysfunction. The study group consisted of 5

APA, Harvard, Vancouver, ISO, and other styles

46

Barbagallo, Federica, Laura Mongioì, Rossella Cannarella, Sandro La Vignera, Rosita Condorelli, and Aldo Calogero. "Sexual Dysfunction in Diabetic Women: An Update on Current Knowledge." Diabetology 1, no. 1 (2020): 11–21. http://dx.doi.org/10.3390/diabetology1010002.

Full text

Abstract:

Diabetes mellitus (DM) is one of the most common chronic diseases worldwide and its prevalence is expected to increase in the coming years. Therefore, updated knowledge of all diabetic complications and their management is essential for the proper treatment of these patients. Sexual dysfunctions are one of the long-term complications of DM in both genders. However, female sexuality is still a taboo and sexual concerns are often overlooked, underdiagnosed, and untreated. The aim of this review is to summarize the current knowledge on the relationship between sexual function and DM in women. In

APA, Harvard, Vancouver, ISO, and other styles

47

Betito, Laurie. "Understanding Female Sexual Dysfunction." Canadian Women's Health Today, April 3, 2024. http://dx.doi.org/10.58931/cwht.2024.119.

Full text

Abstract:

Sexuality is an integral part of our human existence. It is more than a source of pleasure—it is a source of fulfillment, emotional connection, intimacy and empowerment. Unfortunately, for many women worldwide, a satisfying and fulfilling sex life is thwarted by sexual dysfunction. Female sexual dysfunction (FSD) is an all too common and often very distressing condition that encompasses a wide range of difficulties, and affects women of all ages and backgrounds. This condition is characterized by a persistent or recurrent inability to achieve sexual satisfaction, causing the woman distress. Th

APA, Harvard, Vancouver, ISO, and other styles

48

Nakamura, H. S., M. A. M. Hammad, E. A. Chawareb, et al. "(046) EXPLORING GENDER DISPARITIES IN FEMALE AND MALE SEXUAL DYSFUNCTION." Journal of Sexual Medicine 22, Supplement_1 (2025). https://doi.org/10.1093/jsxmed/qdaf068.045.

Full text

Abstract:

Abstract Introduction Female sexual dysfunction (FSD) affects up to 43% of women in the United States compared to male sexual dysfunction (MSD) which affects around 31% of men. Although FSD is largely underdiagnosed and undertreated there is still an increasing interest among the public for treatment and among medical students to specialize in FSD. Given this relationship, it is important to gauge how gender inequality may manifest in public, academic, and professional contexts and how to target these disparities. Objective The aim of the study at hand is to explore gender disparities in FSD a

APA, Harvard, Vancouver, ISO, and other styles

49

Derosa, Giuseppe, Davide Romano, Angela D’Angelo, and Pamela Maffioli. "Female Sexual Dysfunction in Subjects with Type 2 Diabetes Mellitus." Sexuality and Disability, March 6, 2023. http://dx.doi.org/10.1007/s11195-023-09781-3.

Full text

Abstract:

AbstractThe correlation of female sexual dysfunction (FSD) with the degree of glycemic control, the duration and complications of diabetic disease and cardiovascular risk factors are not so clear. The aim of this study was to assess the prevalence of FSD in a sample of females with type 2 diabetes mellitus (T2DM), and to identify factors involved in its pathogenesis. We enrolled 81 females who have T2DM. We administered the female sexual function index (FSFI), self-rating anxiety scale (SAS) and self-rating depression scale (SDS) questionnaires. We also estimated anthropometric parameters, gly

APA, Harvard, Vancouver, ISO, and other styles

50

Di Stasi, Vincenza, Elisa Maseroli, and Linda Vignozzi. "Female Sexual Dysfunction in Diabetes: Mechanisms, Diagnosis and Treatment." Current Diabetes Reviews 18, no. 1 (2022). http://dx.doi.org/10.2174/1573399818666211117123802.

Full text

Abstract:

: Female sexual dysfunction (FSD) is an underinvestigated comorbidity of diabetes mellitus, often not evaluated in diabetes clinics. Diabetic women should be encouraged to talk about this topic by their diabetologist, because these problems could be comorbid to cardio-metabolic alterations, as it happens in the male counterpart. This review summarizes evidence on sexual dysfunction characteristics in diabetic women, exploring possible underlying pathogenic mechanisms. The role of hypoglycemic drugs in this context was also evaluated. To date, no specific questionnaire has been designed for the

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!